RITUXIMAB FOLLOWED BY ABATACEPT FOR PREVENTION OR REVERSAL OF TYPE 1 DIABETES (Protocol TN-25)
Details
Age
Child to Adult
Locations
Barbara Davis Center
Childrens Hospital Colorado
Principal Investigator
Peter Gottlieb
Study ID
Protocol Number: 19-0914
More information available at ClinicalTrials.gov: NCT03929601
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers